Table 2 Comparisons of RANKL, OPG and RANKL/OPG according to disease activity
RA (n = 33) | SpA (n = 32) | OA (n = 18) | p-value* | |||
|---|---|---|---|---|---|---|
DAS28 ≥ 3.2 (n = 15) | DAS28 < 3.2 (n = 18) | DAS28 ≥ 3.2 or ASDAS-CRP ≥ 2.1 (n = 14) | DAS28 < 3.2 or ASDAS-CRP < 2.1 (n = 18) | All patients (n = 18) | ||
RANKL (pg/mL; mean ± SD) | 85 ± 61 | 54 ± 31 | 66 ± 43 | 53 ± 24 | 65 ± 36 | 0.45 |
OPG (pg/mL; mean ± SD) | 18,840 ± 11,460 | 14,800 ± 10,960 | 11,310 ± 12,160 | 21,250 ± 14,270 | 18,160 ± 11,040 | 0.16 |
RANKL/OPG (x103) | 38.6 ± 11.1 | 11.6 ± 10.4 | 16.7 ± 20.8 | 4.7 ± 5.3 | 5.6 ± 5.5 | 0.62 |